PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 10412048-9 1999 12-O-Tetradecanoylphorbol-13-acetate, an activator of PKC, attenuated the phosphorylation of p38 MAP kinase by bFGF, but did not affect the A23187-induced phosphorylation. Tetradecanoylphorbol Acetate 0-36 fibroblast growth factor 2 Mus musculus 111-115 10091935-5 1998 TPA-treated B16F1 cells showed enhanced release of basic FGF (bFGF) and vascular endothelial growth factor (VEGF) and increased angiogenic capacity and lung colony formation in vivo. Tetradecanoylphorbol Acetate 0-3 fibroblast growth factor 2 Mus musculus 51-60 10091935-5 1998 TPA-treated B16F1 cells showed enhanced release of basic FGF (bFGF) and vascular endothelial growth factor (VEGF) and increased angiogenic capacity and lung colony formation in vivo. Tetradecanoylphorbol Acetate 0-3 fibroblast growth factor 2 Mus musculus 62-66 10091935-7 1998 However, both cell lines showed an induction of VEGF as well as bFGF expression by TPA treatment suggesting that in BL6 cells antagonistic factors, inhibiting the angiogenic and metastatic capacity, are induced by this treatment. Tetradecanoylphorbol Acetate 83-86 fibroblast growth factor 2 Mus musculus 64-68 9704334-10 1998 Phorbol 12-myristate 13-acetate (PMA, 2 or 5 nM) protected CCE cells against apoptosis induced by the introduction of TGF-beta 1 and withdrawal of aFGF, bFGF or VEGF, while H7 (50 microM), but not HA1004 (50 microM), abrogated the protective effect of PMA on CCE apoptosis. Tetradecanoylphorbol Acetate 0-31 fibroblast growth factor 2 Mus musculus 153-157 9733598-12 1998 CONCLUSION: IM inhibits bFGF-induced angiogenesis in wild-type, tPA-knockout, and uPA-knockout mice. Tetradecanoylphorbol Acetate 64-67 fibroblast growth factor 2 Mus musculus 24-28 9704334-10 1998 Phorbol 12-myristate 13-acetate (PMA, 2 or 5 nM) protected CCE cells against apoptosis induced by the introduction of TGF-beta 1 and withdrawal of aFGF, bFGF or VEGF, while H7 (50 microM), but not HA1004 (50 microM), abrogated the protective effect of PMA on CCE apoptosis. Tetradecanoylphorbol Acetate 33-36 fibroblast growth factor 2 Mus musculus 153-157 7718627-7 1995 Down-regulation of protein kinase C (PKC) activity by TPA pretreatment repressed the bFGF induction of TIS1 but had little effect on the bFGF-stimulated expression of TIS8. Tetradecanoylphorbol Acetate 54-57 fibroblast growth factor 2 Mus musculus 85-89